This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Tuberculosis


  • Tulane Researchers Working on New Tuberculosis Vaccine
    Researchers at the Tulane National Primate Research Center (TNPRC) are leading efforts to find a new vaccine for tuberculosis, one of the world’s deadliest diseases. Tuberculosis, a contagious infection of the lungs, affected more than 9 million people in 2013, ...More
    October 14, 2015 Posted in News
  • TTUHSC El Paso to Research TB Vaccine
    A $375,000 grant from the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation was awarded to Subramanian Dhandayuthapani, PhD, an associate professor in the Center of Emphasis in Infectious Diseases at the Texas Tech University Health Sciences Center (TTUHSC) El Paso Paul ...More
    September 23, 2015 Posted in News
  • Electronic Reminders Can Help Tuberculosis Patients Stay on Medication
    Reminders to take medication, delivered to patients via an electronic pillbox, may be able to improve adherence to tuberculosis (TB) treatment. The findings, reported this week in PLOS Medicine, are the result of a cluster randomized controlled trial by Shiwen Jiang of the ...More
    September 15, 2015 Posted in News
  • Review of Animal Studies Questions Effects of MVA85A Vaccine on Tuberculosis
    A new systematic review of animal studies testing a vaccine for tuberculosis raises questions about whether the studies provided sufficient evidence to move into trials of children. The new vaccine was a virus-expressing antigen 85A (MVA85A) designed to boost the immunity ...More
    September 9, 2015 Posted in News
  • Rapid TB Testing Aims to Reduce Drug Resistance, Lower Mortality Rate
    Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis (TB), which are much harder and more expensive to treat and which, experts say, represent a ...More
    September 8, 2015 Posted in News
  • TB Researchers Earn NIH Grant to Study Potential for Shortening Treatment Course
    Stop Jeff North, PhD, if you’ve heard this one before: an indole-based drug and a tuberculosis protein meet in a laboratory. There’s a brief interaction, then the drug skates merrily away while the protein is nowhere to be found. It sounds like great news with ...More
    August 4, 2015 Posted in News
  • Novel Toxin for M. tuberculosis is Found
    Despite 132 years of study, no toxin had ever been found for the deadly pathogen Mycobacterium tuberculosis, which infects 9 million people a year and kills more than 1 million. Now, Michael Niederweis, PhD, professor of microbiology at the University of Alabama at ...More
    August 3, 2015 Posted in News
  • On-Chip Processor the First Step in Point-of-Care Tuberculosis and Asthma Diagnostics
    A device to mix liquids utilizing ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma. The device, developed by engineers at Penn State in ...More
    August 3, 2015 Posted in News
  • Scientists Set Sights on Glaucoma Medication to Treat TB
    A new discovery by Michigan State University (MSU) scientists suggests that a common medication used to treat glaucoma could also be used to treat tuberculosis, even the drug-resistant kind. Robert Abramovitch, an MSU microbiologist, along with graduate student ...More
    July 23, 2015 Posted in News